Gladstone NOW: The Campaign Join Us on the Journey✕
Gladstone President Deepak Srivastava moderated a conversation with Jennifer Doudna and Shinya Yamanaka to discuss the potential impact of CRISPR and iPS cells over the coming decade and hear from the two world-class scientists about how they plan to shape the enormous opportunities that lie ahead.
Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for his discovery of induced pluripotent stem cells (iPS cells). And last year, Doudna received the Nobel Prize in Chemistry for her co-discovery of the CRISPR-Cas9 gene-editing technology. Arguably the two most impactful advances of this century, the discoveries by these Gladstone investigators are now accelerating our understanding and treatment of human disease at an unprecedented pace.
Support Discovery Science
Your gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.
3D Shapes of Viral Proteins Point to Previously Unknown Roles
Article
August 26, 2024
3D Shapes of Viral Proteins Point to Previously Unknown Roles
Scientists uncover an ancient immune-evading strategy shared by animal viruses and viruses that infect bacteria; findings may help in the development of new antiviral therapies
News Release Research (Publication) Data Science and Biotechnology Virology Doudna Lab CRISPR/Gene EditingVote for Gladstone in This Year’s ‘STAT Madness’ Tournament
Article
March 1, 2024
Vote for Gladstone in This Year’s ‘STAT Madness’ Tournament
The health and science publication STAT has selected a breakthrough discovery from Gladstone to be part of its annual STAT Madness competition, in which research institutes compete for the title of champion. The winner is deemed the most innovative research institution in the country.
Research (Publication) Cancer Genomic Immunology Doudna Lab CRISPR/Gene EditingCRISPR-Powered ‘Cancer Shredding’ Technique Opens New Possibility for Treating Most Common and Deadly Brain Cancer
Article
November 27, 2023
CRISPR-Powered ‘Cancer Shredding’ Technique Opens New Possibility for Treating Most Common and Deadly Brain Cancer
Gladstone Institutes researchers leveraged CRISPR to target and rapidly destroy glioblastoma cells in an approach that could carry over to other highly mutated cancers
News Release Research (Publication) Cancer Doudna Lab CRISPR/Gene Editing